• ReproCELL
  • SHINSEI CORPORATE INVESTMENT
  • TOP
  • MESSAGE
  • COMPANY
  • TEAM
  • PORTFOLIO
  • NEWS
  • japanese
  • english

Cell Innovation Partners Aims to Create Next Generation Biotechnology Businesses

Message

ReproCELL
Chief Executive Officer of ReproCell Inc.
Chikafumi Yokoyama, PhD

Dr. Yokoyama joined ReproCELL Inc. in 2004 as a general manager of the business development division and ・・・

Read More
SHINSEI CORPORATE INVESTMENT
Chief Executive Officer of Shinsei Corporate Investment Limited
Ippei Matsubara

Mr. Matsubara has served as the Chief Executive Officer since the establishment of Shinsei Corporate Investment・・・

Read More

Could you tell us your motivation behind establishing Cell Innovation Partners?

Yokoyama

I expect that the market for regenerative medicine will significantly expand in the future, and that many venture companies in the field are currently being created. However, in reality, sufficient risk money is not available to stem cell and regenerative ・・・

Matsubara

The Shinsei Bank Group has invested in later-stage venture companies in many fields including IT, energy generation and environmental companies and products and services business since 2004. Considering the various investments in venture companies we have made・・・

Read More